$28.20
+15.81%Year over year
Reported trailing growth
- Revenue
- +16.9%
- EBITDA
- +17.9%
- EBIT
- +31.8%
- EPS
- +115.1%
- Free cash flow
- +35.7%
- Operating cash flow
- +34.4%
Forward estimates
Based on analyst estimates
- Revenue
- +7.6%
- EBITDA
- +33.4%
- EPS
- +55.7%
Three-year CAGR
- Revenue
- +14.7%
- EBITDA
- -1.7%
- EBIT
- +21.3%
- Net income
- -10.0%
- EPS
- -10.3%
- Free cash flow
- +26.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Oct 1, 2026